Bernstein SocGen on Elevance (ELV): 'ELV announces market exits in Medicaid'
Tweet Send to a Friend
Bernstein SocGen Group analyst Lance Wilkes reiterated an Outperform rating and $482.00 price target on Elevance (NYSE: ELV).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
